Partnering with Charles River to advance CNS drug discovery with ioGlutamatergic Neurons™
We spoke to Dr Marijn Vlaming, Dr Mariangela Iovino and Dr Shushant Jain from Charles River to discuss how ioGlutamatergic Neurons are accelerating drug discovery by providing human derived, physiologically relevant models for high throughput screening.
Learn about the benefits of ioGlutamatergic Neurons and how they are accelerating CNS drug discovery:
- By providing standardisation and improving reproducibility for researchers involved in high throughput screening
- Offering a human derived, physiologically relevant model to reliably test compounds
- Reducing the time it takes to culture glutamatergic neurons from over 90 days to just 10-14 days
Find out more about our ioGlutamatergic Neurons download the brochure here.
bit.bio and Charles River have partnered for translational drug development. Learn how you can screen and profile at Charles River with bit.bio ioCells.
Dr Marijn Vlaming | Head of Biology, et al.
Charles River & bit.bio